-
By administrator
- In Blog
Most researchers know that IMRAD stands for Introduction, Methods, Results, and Discussion. Very few of them know what each section is supposed to do. Even fewer know that writing these sections in the order they appear in the paper is a mistake. This error is one of the top reasons clinical manuscripts get rejected during structural review before a reviewer even looks at the science.
Writing the manuscript in the order it will be read feels logical. You start with the intro and end with the discussion. But this approach often causes first drafts to fall apart. When you write the introduction first, you don’t yet have the final results in front of you. You end up guessing which gaps in the literature matter or which background details are relevant. You’re writing blind.
The Strategic IMRAD Structure Writing Order
To build a strong paper, you have to separate the reading order from the writing order. The most effective way to write a clinical paper is: Results, then Methods, then Introduction, and finally Discussion.
Writing the results first gives you a foundation of facts. Once you know what you found, you can explain how you found it in the methods. After that, you can write an introduction that leads the reader directly to your actual findings. You only write the discussion last because you can’t interpret data you haven’t clearly documented yet.
How to Write a Focused Introduction
The introduction should answer one question: why did this research need to happen? Its only job is to move the reader from a general problem to your specific study objective.
Start by stating the problem in the current literature. Identify the exact gap your study addresses. End the section with your study objective. Do not include background information just for the sake of it. If the information doesn’t lead directly to your objective, cut it.
Making Your Methods Replicable
The methods section answers how the study was done. It must have enough detail for another researcher to copy your work exactly. This is where most authors fail because they assume the reader already knows the context. Reviewers don’t share your context, and they will reject a paper that is too brief.
Your methods section must include these three elements:
- Study design in the first sentence. For example, stating “This was a cross-sectional study of 150 regular blood donors” immediately tells the reviewer what to expect.
- A clear population description. List who was included and who was excluded, and explain why.
- The primary outcome measure. Don’t just say what you measured. Explain exactly how you measured it, such as using an ELISA test for serum ferritin concentration.
Reporting Results Without Interpretation
The results section answers what was found. There is one rule here with no exceptions: report the data, but do not interpret it.
Many authors break this rule in the last sentence of a paragraph. They might report that female donors had lower ferritin levels and then add that this “suggests” a need for different donation intervals. The word “suggests” is an interpretation. That sentence belongs in the discussion, not the results.
A clean results section uses specific numbers and lists primary and secondary outcomes in sequence. Include all adverse or unexpected findings. If you see the words “suggest,” “indicate,” or “demonstrate that” followed by a conclusion, move that text to the discussion.
Structuring the Discussion for Maximum Impact
The discussion is the hardest part to write because it has four distinct jobs. If you mix these up, the paper loses its logic.
First, provide a plain language summary. Write one sentence that states the primary finding so that someone outside your specialty can understand it. Do not just repeat the results numbers here.
Second, compare your findings to existing literature. Explain if your results are consistent with previous studies. You must use specific citations. Saying a finding is “consistent with previous studies” without a citation will lead to a rejection at any indexed journal.
Third, state the clinical or practical implications. Tell the reader what practitioners or policymakers should do differently because of your data. Avoid vague phrases like “further research is needed.” That is an admission that you haven’t thought about what your data actually supports.
Fourth, list the limitations. Every study has them. State them clearly and explain how they affect your conclusions. Omitting limitations doesn’t make your study look stronger. It tells the reviewer you aren’t thinking critically about your own work.
Avoiding Common IMRAD Structure Errors
Structural review is the first hurdle of publication. Many papers fail here because the boundaries between sections are blurred.
The most common breach is the results-discussion overlap. When authors put interpretation in the results or new data in the discussion, the manuscript fails. The results section is for facts; the discussion is for meanings.
Another common failure is the “missing detail” in methods. Authors often put the study design in the third paragraph instead of the first sentence. This forces the reviewer to hunt for the basic premise of the study, which creates a negative first impression.
Final Thoughts on Clinical Manuscript Success
Following the IMRAD structure strictly improves your chances of publication. By writing your results first, you ensure the rest of the paper stays focused on the actual data. Keep your introduction lean, your methods detailed, and your results free of opinion.
When you treat each section as a tool to answer one specific question, the paper flows naturally. This removes the guesswork from your first draft and stops you from writing blind. Use a checklist to verify each section does its job before you hit submit. If you stick to this sequence, you’ll spend less time rewriting and more time getting your research into the hands of other clinicians.